---
document_datetime: 2023-09-21 19:03:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sabervel-epar-all-authorised-presentations_en.pdf
document_name: sabervel-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5651408
conversion_datetime: 2025-12-22 00:48:28.543328
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) Name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging authorised   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------------|-------------|
| EU/1/12/765/001  | Sabervel          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 28 tablets  |
| EU/1/12/765/002  | Sabervel          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 90 tablets  |
| EU/1/12/765/003  | Sabervel          | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 28 tablets  |
| EU/1/12/765/004  | Sabervel          | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 90 tablets  |
| EU/1/12/765/005  | Sabervel          | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 28 tablets  |
| EU/1/12/765/006  | Sabervel          | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 90 tablets  |
| EU/1/12/765/007  | Sabervel          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 90 tablets  |
| EU/1/12/765/008  | Sabervel          | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 28 tablets  |
| EU/1/12/765/009  | Sabervel          | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 90 tablets  |
| EU/1/12/765/010  | Sabervel          | 75 mg      | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 56 tablets  |
| EU/1/12/765/011  | Sabervel          | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 56 tablets  |
| EU/1/12/765/012  | Sabervel          | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu-PVDC)      | 56 tablets  |

## Strength 75 mg 75 mg 150 mg 150 mg 300 mg 300 mg 75 mg 150 mg 300 mg 75 mg 150 mg 300 mg Medicinal product no longer authorised